Zhengye Biotechnology Holding Limited
ZYBT
$2.01
-$0.02-0.99%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.75M | 2.86M | 1.17M | 1.18M | 2.30M |
| Total Receivables | 12.13M | 12.62M | 12.61M | 12.69M | 14.02M |
| Inventory | 7.98M | 8.30M | 8.97M | 9.03M | 8.22M |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.48M | 1.54M | 3.35M | 3.38M | 2.15M |
| Total Current Assets | 24.33M | 25.31M | 26.11M | 26.28M | 26.69M |
|
|
|||||
| Total Current Assets | 24.33M | 25.31M | 26.11M | 26.28M | 26.69M |
| Net Property, Plant & Equipment | 34.96M | 36.38M | 35.00M | 35.23M | 37.12M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 3.12M | 3.25M | 3.39M | 3.41M | 3.45M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 5.17M | 5.38M | 2.60M | 2.62M | 3.23M |
| Total Assets | 67.58M | 70.32M | 67.10M | 67.53M | 70.50M |
|
|
|||||
| Total Accounts Payable | 5.89M | 6.12M | 5.73M | 5.77M | 6.44M |
| Total Accrued Expenses | 109.70K | 114.20K | 74.70K | 75.20K | 75.60K |
| Short-term Debt | 10.22M | 10.63M | 11.00M | 11.07M | 11.26M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 985.10K | 1.03M | 1.03M | 1.04M | -- |
| Total Finance Division Other Current Liabilities | 1.42M | 1.48M | 1.08M | 1.09M | 3.41M |
| Total Other Current Liabilities | 1.42M | 1.48M | 1.08M | 1.09M | 3.41M |
| Total Current Liabilities | 18.62M | 19.38M | 18.91M | 19.03M | 21.19M |
|
|
|||||
| Total Current Liabilities | 18.62M | 19.38M | 18.91M | 19.03M | 21.19M |
| Long-Term Debt | 657.60K | 684.30K | -- | -- | 1.41M |
| Short-term Debt | 10.22M | 10.63M | 11.00M | 11.07M | 11.26M |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | 54.10K | 54.40K | 55.40K |
| Total Liabilities | 19.28M | 20.06M | 18.97M | 19.09M | 22.65M |
|
|
|||||
| Common Stock & APIC | 27.83M | 28.96M | 27.96M | 28.14M | 28.65M |
| Retained Earnings | 11.07M | 11.52M | 10.80M | 10.87M | 9.83M |
| Treasury Stock & Other | 400.00 | 400.00 | 400.00 | 400.00 | -- |
| Total Common Equity | 38.90M | 40.48M | 38.76M | 39.01M | 38.48M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 38.90M | 40.48M | 38.76M | 39.01M | 38.48M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 9.40M | 9.78M | 9.38M | 9.44M | 9.37M |
| Total Equity | 48.30M | 50.26M | 48.14M | 48.44M | 47.85M |
|
|
|||||